Table 4.
Differences in plasma FA levels among the study subjects as determined by GC-MS analysis according to WBC levels.
Relative peak area | Total (n = 95) | pa | pb | ||
---|---|---|---|---|---|
WBC <4.0(n = 38) | 4.0≤ WBC <8.0(n = 38) | WBC ≥8.0(n = 19) | |||
SFAs§ | 6.361 ± 0.174 | 5.845 ± 0.219 | 6.044 ± 0.238 | 0.105 | 0.297 |
Lauric acid (C12:0)† | 0.031 ± 0.004 | 0.023 ± 0.002 | 0.025 ± 0.002 | 0.072 | 0.324 |
Myristic acid (C14:0)§ | 0.203 ± 0.014 | 0.180 ± 0.011 | 0.219 ± 0.015 | 0.141 | 0.154 |
Pentadecylic acid (C15:0)† | 0.032 ± 0.003 | 0.021 ± 0.003 | 0.029 ± 0.005 | 0.039 | 0.148 |
Palmitic acid (C16:0)§ | 4.220 ± 0.127 | 3.939 ± 0.155 | 3.885 ± 0.144 | 0.175 | 0.518 |
Stearic acid (C18:0)§ | 1.836 ± 0.047a, b | 1.651 ± 0.057b | 1.847 ± 0.082a | 0.019 | 0.030 |
Arachidic acid (C20:0)§ | 0.039 ± 0.002a, b | 0.032 ± 0.002b | 0.039 ± 0.004a | 0.032 | 0.050 |
Behenic acid (C22:0)§ | 0.088 ± 0.006a, b | 0.072 ± 0.006b | 0.092 ± 0.009a | 0.045 | 0.040 |
MUFAs§ | 1.211 ± 0.050 | 1.123 ± 0.050 | 1.209 ± 0.070 | 0.365 | 0.254 |
Palmitoleic acid (C16:1ω7)§ | 0.141 ± 0.008 | 0.118 ± 0.007 | 0.143 ± 0.011 | 0.041 | 0.052 |
cis-10-Heptadecenoic acid (C17:1ω7)§ | 0.011 ± 0.001a, b | 0.010 ± 0.001b | 0.013 ± 0.001a | 0.052 | 0.028 |
Oleic acid (C18:1ω9)§ | 1.049 ± 0.043 | 0.986 ± 0.043 | 1.043 ± 0.059 | 0.503 | 0.337 |
Eicosenoic acid (C20:1ω9)† | 0.011 ± 0.001 | 0.009 ± 0.000 | 0.011 ± 0.001 | 0.112 | 0.179 |
Erucic acid (C22:1ω9)§ | 0.010 ± 0.002 | 0.006 ± 0.001 | 0.008 ± 0.001 | 0.126 | 0.096 |
Nervonic acid (C24:1ω9)§ | 0.045 ± 0.003 | 0.037 ± 0.004 | 0.044 ± 0.006 | 0.095 | 0.114 |
ω-3 PUFAs† | 0.635 ± 0.042 | 0.402 ± 0.033 | 0.494 ± 0.062 | <0.001 | 0.034 |
α-Linolenic acid (C18:3ω3)§ | 0.128 ± 0.011 | 0.087 ± 0.009 | 0.090 ± 0.013 | 0.006 | 0.340 |
Eicosapentaenoic acid (C20:5ω3)† | 0.151 ± 0.013 | 0.092 ± 0.010 | 0.106 ± 0.018 | 0.002 | 0.601 |
Docosapentaenoic acid (C22:5ω3)† | 0.036 ± 0.004 | 0.026 ± 0.004 | 0.026 ± 0.004 | 0.171 | 0.407 |
Docosahexaenoic acid (C22:6ω3)† | 0.320 ± 0.025a, b | 0.197 ± 0.018b | 0.271 ± 0.035a | 0.002 | 0.018 |
ω-6 PUFAs† | 3.420 ± 0.168 | 2.842 ± 0.147 | 3.235 ± 0.329 | 0.015 | 0.383 |
Linoleic acid (C18:2ω6)† | 2.617 ± 0.153 | 2.122 ± 0.121 | 2.460 ± 0.283 | 0.013 | 0.393 |
γ-Linolenic acid (C18:3ω6)† | 0.072 ± 0.012 | 0.037 ± 0.008 | 0.055 ± 0.013 | 0.041 | 0.160 |
Eicosadienoic acid (C20:2ω6)§ | 0.023 ± 0.001 | 0.020 ± 0.001 | 0.024 ± 0.002 | 0.083 | 0.079 |
Dihomo-γ-linolenic acid (C20:3ω6)§ | 0.102 ± 0.005b | 0.093 ± 0.004b | 0.120 ± 0.009a | 0.023 | 0.008 |
Arachidonic acid (C20:4ω6)§ | 0.579 ± 0.021 | 0.545 ± 0023 | 0.536 ± 0.036 | 0.341 | 0.572 |
Docosatetraenoic acid (C22:4ω6)§ | 0.028 ± 0.003b | 0.025 ± 0.003b | 0.039 ± 0.007a | 0.059 | 0.005 |
FA METABOLISM-RELATED ENZYMES (ACTIVITIES) | |||||
Δ5-desaturase§ | 6.152 ± 0.331a | 6.031 ± 0.229a | 4.651 ± 0.291b | 0.002 | 0.001 |
Δ6-desaturase§ | 0.025 ± 0.004 | 0.016 ± 0.002 | 0.021 ± 0.003 | 0.128 | 0.331 |
C16 Δ9-desaturase§ | 0.033 ± 0.002a, b | 0.030 ± 0.001b | 0.036 ± 0.002a | 0.021 | 0.025 |
C18 Δ9-desaturase§ | 0.569 ± 0.016 | 0.597 ± 0.015 | 0.564 ± 0.019 | 0.290 | 0.365 |
Elongase§ | 0.441 ± 0.010b | 0.424 ± 0.007b | 0.475 ± 0.011a | 0.003 | 0.004 |
Mean ± standard error (SE).
variables tested following logarithmic transformation. pa-values of the continuous variables were derived from one-way ANOVA;
variables tested by a nonparametric test (Kruskal-Wallis test). pb-values are pa-values adjusted ~ for age, sex, and weight. After the adjustment, significant changes among the groups are marked with the different alphabet letters (a, b, and c) following Bonferroni post hoc test. All p-values < 0.05 were considered significant. Δ5-desaturase, arachidonic acid/dihomo-γ-linoienic acid; Δ6-desaturase, γ-linolenic acid/linoleic acid; C16 Δ9-desaturase, palmitoleic acid/palmitic acid; C18 Δ9-desaturase, oleic acid/stearic acid; Elongase, stearic acid/palmitic acid.
FA: fatty acid. MUFAs: monounsaturated fatty acids. PUFAs: polyunsaturated fatty acids. SFAs: saturated fatty acids.